全文获取类型
收费全文 | 1274篇 |
免费 | 119篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 60篇 |
妇产科学 | 40篇 |
基础医学 | 126篇 |
口腔科学 | 30篇 |
临床医学 | 198篇 |
内科学 | 261篇 |
皮肤病学 | 15篇 |
神经病学 | 43篇 |
特种医学 | 277篇 |
外科学 | 124篇 |
综合类 | 27篇 |
一般理论 | 3篇 |
预防医学 | 57篇 |
眼科学 | 7篇 |
药学 | 82篇 |
中国医学 | 5篇 |
肿瘤学 | 41篇 |
出版年
2023年 | 9篇 |
2021年 | 13篇 |
2020年 | 12篇 |
2019年 | 8篇 |
2018年 | 25篇 |
2017年 | 13篇 |
2016年 | 23篇 |
2015年 | 23篇 |
2014年 | 32篇 |
2013年 | 35篇 |
2012年 | 23篇 |
2011年 | 28篇 |
2010年 | 44篇 |
2009年 | 62篇 |
2008年 | 39篇 |
2007年 | 27篇 |
2006年 | 31篇 |
2005年 | 22篇 |
2004年 | 20篇 |
2003年 | 29篇 |
2002年 | 22篇 |
2001年 | 26篇 |
2000年 | 20篇 |
1999年 | 25篇 |
1998年 | 57篇 |
1997年 | 59篇 |
1996年 | 67篇 |
1995年 | 50篇 |
1994年 | 46篇 |
1993年 | 49篇 |
1992年 | 27篇 |
1991年 | 18篇 |
1990年 | 30篇 |
1989年 | 44篇 |
1988年 | 39篇 |
1987年 | 42篇 |
1986年 | 39篇 |
1985年 | 32篇 |
1984年 | 22篇 |
1983年 | 12篇 |
1982年 | 26篇 |
1981年 | 19篇 |
1980年 | 14篇 |
1979年 | 10篇 |
1978年 | 7篇 |
1977年 | 15篇 |
1976年 | 15篇 |
1975年 | 16篇 |
1966年 | 3篇 |
1928年 | 6篇 |
排序方式: 共有1400条查询结果,搜索用时 15 毫秒
51.
52.
Human platelet membrane glycoproteins IIb and IIIa (GPIIb and IIIa) were incorporated into phospholipid vesicles by the reverse-phase technique to assess the ability of GPIIb and IIIa to function as a Ca2+ channel. Movement of Ca2+ across the lipid bilayer was quantitated by injection of proteoliposomes with encapsulated Fura-2 into Ca2+ buffers and measurement of Fura-2 fluorescence as an indicator of Ca2+ influx. Reciprocally, to assess the function of proteins in an inside-out orientation, Ca2+-loaded vesicles were injected into Ca2+-free buffer and Ca2+ efflux monitored by a calcium electrode. Incorporation of the IIb-IIIa complex produced significant facilitation of Ca2+ movement across the lipid bilayer. No net transmembrane Ca2+ movement was seen with dissociated IIb and IIIa. Movement of Ca2+ was proportional to the transmembrane Ca2+ gradient. Ca2+ movement into the vesicles was inversely proportional to extravesicular NaCl from 25 to 150 mmol/L, analogous to several studies in the intact platelet. Adenosine triphosphate had no effect on Ca2+ movement into or out of the vesicles. Specific inhibition of a Ca2+ shift into the vesicles was seen with M148, a monoclonal antibody to IIb/IIIa, while no inhibition was observed with a panel of other anti-IIb/IIIa monoclonal antibodies. This suggests that a specific site on the complex or orientation of the complex is essential for calcium channel function. These data demonstrate that the GPIIb/IIIa complex can serve as a passive Ca2+ channel across a phospholipid bilayer and has the potential to play a role in Ca2+ flux across the platelet plasma membrane. 相似文献
53.
Hasegawa DK; Bennett AJ; Coccia PF; Ramsay NK; Nesbit ME; Krivit W; Edson JR 《Blood》1980,56(4):585-595
Factor V deficiency has been identified in 8 of 8 patients 7--20 yr of age, with Philadelphia-positive (Ph1+) chronic myelogenous leukemia (CML). In these 8 patients, factor V deficiency was not due to hepatic dysfunction, factor V inhibitors, or disseminated intravascular coagulation. In 3 patients, factor V activity rose 10%--12% (0.10--0.12 U/ml) after the infusion of 28--31 ml/kg body weight of fresh frozen plasma (FFP). The rise persisted less than 14 hr. The mean measured postinfusion rise in factor V was 18% of the expected rise calculated from the volume of FFP infused in the patients' plasma volume. In 4 patients, a small transient rise in factor V activity occurred after splenectomy or plateletpheresis. Factor V deficiency was completely corrected after a marked reduction in bone marrow cellularity in 2 patients with Ph1+ CML treated with extensive chemotherapy, total body irradiation, and bone marrow transplantation. Factor V deficiency was retrospectively observed in 6 of 20 patients, ages 20--80 yr, with Ph1+ CML and 3 of 6 patients with other myeloproliferative disorders. The factor V deficiency appears to be associated with the large myeloid- megakaryocytic cell mass characteristic of CML and other myeloproliferative disorders. 相似文献
54.
55.
56.
J Uhlendorf A Miermont T Delaveau G Charvin F Fages S Bottani G Batt P Hersen 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(35):14271-14276
Gene expression plays a central role in the orchestration of cellular processes. The use of inducible promoters to change the expression level of a gene from its physiological level has significantly contributed to the understanding of the functioning of regulatory networks. However, from a quantitative point of view, their use is limited to short-term, population-scale studies to average out cell-to-cell variability and gene expression noise and limit the nonpredictable effects of internal feedback loops that may antagonize the inducer action. Here, we show that, by implementing an external feedback loop, one can tightly control the expression of a gene over many cell generations with quantitative accuracy. To reach this goal, we developed a platform for real-time, closed-loop control of gene expression in yeast that integrates microscopy for monitoring gene expression at the cell level, microfluidics to manipulate the cells' environment, and original software for automated imaging, quantification, and model predictive control. By using an endogenous osmostress responsive promoter and playing with the osmolarity of the cells environment, we show that long-term control can, indeed, be achieved for both time-constant and time-varying target profiles at the population and even the single-cell levels. Importantly, we provide evidence that real-time control can dynamically limit the effects of gene expression stochasticity. We anticipate that our method will be useful to quantitatively probe the dynamic properties of cellular processes and drive complex, synthetically engineered networks. 相似文献
57.
Previous studies of motor laterality in dogs have produced some conflicting results, with inconsistencies in lateral biases across sexes, over time, and across tasks. The current study modified published food-retrieval and tape-removal tests before applying them to 43 dogs. It showed that results derived from 50 observations of a food-retrieval task (Kong? test) were consistent with 100 observations. Further, observations during both Kong? and the tape-removal tests were consistent both within and between observers. Lateralisation results from both the Kong? and Tape tests were generally consistent between breeds and sexes and over time, the only exceptions being the categorical groups during the Tape test and the strength of lateralisation in the Kong? test. Of greatest interest in this study was the lack of consistency between results from the two different motor lateralisation tasks conducted. Given that motor lateralisation is said to reflect differences in brain structure or function, differences in task results may indicate differing complexities of the two tasks. 相似文献
58.
非酒精性脂肪性肝炎(non—alcoholicsteatohepatitis,NASH)现已成为肝移植愈来愈重要的基础肝病。鉴于晚期NASH患者常并存多种影响肝移植转归的临床问题,而至今尚无针对NASH患者进行肝移植的评估和治疗指南,为此英国移植学会(British Transplant Society,BTS)邀请相关专家制定了指南,以指导肝移植前后NASH患者的处理。 相似文献
59.
Florian ME Wagenlehner Christoph Lichtenstern Caroline Rolfes Konstantin Mayer Florian Uhle Wolfgang Weidner Markus A Weigand 《International journal of urology》2013,20(10):963-970
Urosepsis is defined as sepsis caused by a urogenital tract infection. Urosepsis in adults comprises approximately 25% of all sepsis cases, and is in most cases due to complicated urinary tract infections. The urinary tract is the infection site of severe sepsis or septic shock in approximately 10–30% of cases. Severe sepsis and septic shock is a critical situation, with a reported mortality rate nowadays still ranging from 30% to 40%. Urosepsis is mainly a result of obstructed uropathy of the upper urinary tract, with ureterolithiasis being the most common cause. The complex pathogenesis of sepsis is initiated when pathogen or damage‐associated molecular patterns recognized by pattern recognition receptors of the host innate immune system generate pro‐inflammatory cytokines. A transition from the innate to the adaptive immune system follows until a TH2 anti‐inflammatory response takes over, leading to immunosuppression. Treatment of urosepsis comprises four major aspects: (i) early diagnosis; (ii) early goal‐directed therapy including optimal pharmacodynamic exposure to antimicrobials both in the plasma and in the urinary tract; (iii) identification and control of the complicating factor in the urinary tract; and (iv) specific sepsis therapy. Early adequate tissue oxygenation, adequate initial antibiotic therapy, and rapid identification and control of the septic focus in the urinary tract are critical steps in the successful management of a patient with urosepsis, which includes early imaging, and an optimal interdisciplinary approach encompassing emergency unit, urological and intensive‐care medicine specialists. 相似文献
60.